Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host.
Alveolar echinococcosis
Benzimidazole
Immunity
Immunomodulation
Treatment
Journal
Experimental parasitology
ISSN: 1090-2449
Titre abrégé: Exp Parasitol
Pays: United States
ID NLM: 0370713
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
08
07
2020
revised:
08
09
2020
accepted:
29
09
2020
pubmed:
4
10
2020
medline:
15
12
2020
entrez:
3
10
2020
Statut:
ppublish
Résumé
Alveolar echinococcosis (AE) is a deadly parasitic disease that requires lifelong treatment with albendazole. Development of host immunity is pivotal with regard to the clinical outcome of AE, but its influence on conventional albendazole treatment is unknown. Using T-cell deficient athymic nude mice, we demonstrated that functional immunity is required for albendazole to be efficacious against murine AE. These results call for attention given the increasing number of immunocompromised patients with AE.
Identifiants
pubmed: 33010287
pii: S0014-4894(20)30363-5
doi: 10.1016/j.exppara.2020.108013
pii:
doi:
Substances chimiques
Anticestodal Agents
0
Albendazole
F4216019LN
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108013Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.